A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
West China Hospital
Orano Med LLC
Amgen
Instituto do Cancer do Estado de São Paulo
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Vastra Gotaland Region
Fundación de investigación HM
Rezolute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Providence Health & Services
National Cancer Institute (NCI)
RayzeBio, Inc.
Melanoma and Skin Cancer Trials Limited
National Health Research Institutes, Taiwan
National Institutes of Health Clinical Center (CC)
ITM Solucin GmbH
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Turning Point Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Ipsen
RayzeBio, Inc.
Boston Scientific Corporation
Melanoma and Skin Cancer Trials Limited
National Institutes of Health Clinical Center (CC)
Centre Hospitalier Universitaire Dijon
Exelixis
University Health Network, Toronto
Methodist Health System
Novartis
M.D. Anderson Cancer Center
Crinetics Pharmaceuticals Inc.
University of Wisconsin, Madison
Centre Oscar Lambret
Stanford University
University of California, San Francisco
Huazhong University of Science and Technology
M.D. Anderson Cancer Center
University of California, Davis
Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc.
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Hoffmann-La Roche
Grupo Espanol de Tumores Neuroendocrinos